Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia gravis (gMG), one of two drugs that the company hopes will shake up the ...
The UK regulatory authority has cleared the path for some patients with generalised myasthenia gravis (gMG ... medicines to patients with few treatment options. gMG is a rare and chronic ...
DARZALEX growth was driven by share gains of over 3 points across all lines of therapy, and importantly ... growth and adoption in generalized myasthenia gravis, where VYVGART Hytrulo with ...
Fast Company on MSN13d
This tiny Pennsylvania community was deemed ‘expendable.’ So toxic waste keeps flowingSo we have concerns that the treatment that Max is performing is not adequate ... She would later be diagnosed with ...
So we have concerns that the treatment that Max is performing ... She would later be diagnosed with myasthenia gravis, an autoimmune disease. Many residents in Yukon have signs in their yards ...
Myasthenia gravis is a neuromuscular junction disorder with a hallmark of progressive muscle weakness and frequent ...
The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and Drug Administration (FDA) approval of the expanded indication of Alexion/AstraZeneca’s eculizumab (Soliris) for pediatric patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback